FMR LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$1,466,000
-12.3%
242,764
+39.8%
0.00%
Q4 2017$1,671,000
-17.2%
173,684
-23.5%
0.00%
Q3 2017$2,017,000
-37.4%
227,084
-10.8%
0.00%
Q2 2017$3,221,000
+26.1%
254,588
+4.7%
0.00%
Q1 2017$2,555,000
+8.2%
243,084
-5.3%
0.00%
Q4 2016$2,362,000
-72.3%
256,745
-64.5%
0.00%
-100.0%
Q3 2016$8,521,000
-17.1%
722,755
-9.0%
0.00%0.0%
Q2 2016$10,283,000
-47.8%
794,645
-35.5%
0.00%
-66.7%
Q1 2016$19,685,000
-72.1%
1,231,084
-50.1%
0.00%
-70.0%
Q4 2015$70,630,000
+0.6%
2,466,9840.0%0.01%0.0%
Q3 2015$70,210,000
-20.4%
2,466,984
+0.4%
0.01%
-9.1%
Q2 2015$88,255,000
+23.6%
2,456,984
+100.0%
0.01%
+22.2%
Q1 2015$71,412,000
+62.9%
1,228,492
+18.2%
0.01%
+50.0%
Q4 2014$43,837,000
+9.1%
1,039,770
+0.3%
0.01%
+20.0%
Q3 2014$40,183,000
+24.2%
1,036,1700.0%0.01%
+25.0%
Q2 2014$32,360,000
-30.2%
1,036,170
-7.5%
0.00%
-33.3%
Q1 2014$46,388,000
+3484.9%
1,119,670
+3249.0%
0.01%
Q4 2013$1,294,00033,4330.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2017
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders